Publications

Who pays to treat malaria and how much? Analysis of the cost of illness, equity and economic burden of malaria in Uganda.

SNYMAN, K; PITT, C; Aturia, A; Aber, J; Gonahasa, S; Namuganga, JF; Nankabirwa, J; Arinaitwe, E; Maiteki-Sebuguzi, C; Katamba, H; Opigo, J; Matovu, F; Dorsey, G; Kamya, MR; Ochieng, W; Staedke, SG;

2024

Health Policy and Planning, (2024).40 1 10.1093/heapol/czae093.

Workplace-based learning in district health leadership and management strengthening: a framework synthesis.

Kiarie, G; GILSON, L; Orgill, M;

2024

Health policy and planning, (2024).40 1 10.1093/heapol/czae095.

Validity of a visual analogue scale to measure and value the perceived level of sanitation: evidence from Ghana and Mozambique.

Cheung, HH; Adriano, Z; Dwumfour-Asare, B; Nyarko, KB; Scott, P; Nala, R; Brown, J; CUMMING, O; ROSS, I;

2024

Health policy and planning, (2024).40 1 10.1093/heapol/czae092.

Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study.

You, T; Zhao, X; Pan, C; Gao, M; Hu, S; LIU, Y; Zhang, Y; Qiao, Y; Zhao, F; Jit, M;

2024

The Lancet regional health. Western Pacific, (2024).52, 10.1016/j.lanwpc.2024.101209.

Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey.

MOGASALE, VV; Sinha, A; John, J; Hasan Farooqui, H; Ray, A; Chantler, T; Mogasale, V; Dhoubhadel, BG; EDMUNDS, WJ; Clark, A; ABBAS, K;

2024

BMJ public health, (2024).2 2 10.1136/bmjph-2024-001089.

Corrigendum to "Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina" [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234].

Guiñazú, G; Dvorkin, J; Mahmud, S; Baral, R; Pecenka, C; Libster, R; CLARK, A; Caballero, MT;

2024

Vaccine, (2024).44, 10.1016/j.vaccine.2024.126402.

Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial.

Afolabi, BB; Babah, OA; Adeyemo, TA; Balogun, M; BANKE-THOMAS, A; Abioye, AI; Akinajo, OR; Galadanci, HS; Quao, RA; Adelabu, H; Sam-Agudu, NA; Adaramoye, VO; Abubakar, A; Banigbe, B; Olorunfemi, G; Beňová, L; Larsson, EC; Annerstedt, KS; HANSON, C; Thornton, J; IVON Trial Investigators,;

2024

The Lancet Global health, (2024).12 10 10.1016/S2214-109X(24)00239-0.

Typhoid conjugate vaccine implementation in India: A review of supportive evidence.

MOGASALE, VV; Sinha, A; John, J; Hasan Farooqui, H; Ray, A; CHANTLER, T; Mogasale, V; Gopal Dhoubhadel, B; John Edmunds, W; CLARK, A; ABBAS, K;

2024

Vaccine: X, (2024).21, 10.1016/j.jvacx.2024.100568.

Exploring Heterogeneity in the Cost-Effectiveness of High-Flow Nasal Cannula Therapy in Acutely Ill Children-Insights From the Step-Up First-line Support for Assistance in Breathing in Children Trial Using a Machine Learning Method.

Hattab, Z; Moler-Zapata, S; Doherty, E; SADIQUE, Z; Ramnarayan, P; O'NEILL, S;

2024

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, (2024).28 1 10.1016/j.jval.2024.08.008.

Analysis of factors associated with use of real-world data in single technology appraisals of cancer drugs by the National Institute for Health and Care Excellence.

KANG, J; CAIRNS, J;